loading
Schlusskurs vom Vortag:
$0.014
Offen:
$0.0141
24-Stunden-Volumen:
7,635
Relative Volume:
0.17
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+7.14%
1M Leistung:
-24.24%
6M Leistung:
+25.00%
1J Leistung:
-41.63%
1-Tages-Spanne:
Value
$0.014
$0.015
1-Wochen-Bereich:
Value
$0.014
$0.0169
52-Wochen-Spanne:
Value
$0.0009
$0.0698

Nls Pharmaceutics Ag Stock (NLSPW) Company Profile

Name
Firmenname
Nls Pharmaceutics Ag
Name
Telefon
41 44 512 21 50
Name
Adresse
The Circle 6, Zurich
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
NLSPW's Discussions on Twitter

Vergleichen Sie NLSPW mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NLSPW
Nls Pharmaceutics Ag
0.015 0 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
366.54 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.00 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.93 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
661.83 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
288.18 35.49B 3.81B -644.79M -669.77M -6.24

Nls Pharmaceutics Ag Aktie (NLSPW) Neueste Nachrichten

pulisher
04:52 AM

Custom watchlist performance reports with NLS Pharmaceutics AGTechnical Chart Summary for Momentum Stocks - Newser

04:52 AM
pulisher
01:17 AM

Can trapped investors hope for a rebound in NLS Pharmaceutics AGAI Stock Movement Forecast with Accuracy - Newser

01:17 AM
pulisher
01:04 AM

What machine learning models say about NLS Pharmaceutics AG Equity WarrantPrice Movement and Market Sentiment Analysis - Newser

01:04 AM
pulisher
12:11 PM

Using data models to predict NLS Pharmaceutics AG stock movementFree Low Risk Buy Zone Opportunity Watch - Newser

12:11 PM
pulisher
Aug 09, 2025

Will NLS Pharmaceutics AG Equity Warrant stock recover after recent dropWeekly Stock Picks with Trend Confidence - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

How to escape a deep drawdown in NLS Pharmaceutics AGConservative Asset Allocation Risk Analysis - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Why NLS Pharmaceutics AG Equity Warrant stock attracts strong analyst attentionMarket Liquidity and Price Flow Analysis - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

NLS Pharmaceutics Regains Compliance With Nasdaq Stockholders' Equity Requirement - 富途牛牛

Aug 09, 2025
pulisher
Aug 09, 2025

Building trade automation scripts for NLS Pharmaceutics AGFree Wealth Building Stock Market Ideas - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

How to escape a deep drawdown in NLS Pharmaceutics AG Equity WarrantPattern Breakout Prediction for Short Term - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Chart based exit strategy for NLS Pharmaceutics AG Equity WarrantAI Screener Based Stock Summary Report - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

NLS Pharmaceutics (NASDAQ:NLSP) Rating Increased to Hold at Wall Street Zen - Defense World

Aug 09, 2025
pulisher
Aug 09, 2025

Heatmap analysis for NLS Pharmaceutics AG and competitorsFree AI Driven Buy Alert Trade Blueprint - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Is NLS Pharmaceutics AG Equity Warrant still worth holding after the dipForecasting Stock Moves with AI Insights - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Can technical indicators confirm NLS Pharmaceutics AG’s reversalRSI and MACD Signal Summary with Trends - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Volume spikes in NLS Pharmaceutics AG stock – what they meanBuy Signal System Based on Price Action - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Risk adjusted return profile for NLS Pharmaceutics AG Equity Warrant analyzedHigh Probability Trade Outcome Prediction - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Does NLS Pharmaceutics AG Equity Warrant stock pay reliable dividendsTechnical Confirmation System with Signal Alerts - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Developing predictive dashboards with NLS Pharmaceutics AG Equity Warrant dataFree Weekly Setup With 3x Return Potential - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Candlestick signals on NLS Pharmaceutics AG stock todayFree Daily Growth Stock Pick Reports - Newser

Aug 08, 2025
pulisher
Aug 06, 2025

Measuring NLS Pharmaceutics AG Equity Warrant’s beta against major indicesFree AI Based High Gain Watchlist Scanner - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Analyzing net buyer seller activity in NLS Pharmaceutics AGMomentum Screener with Buy and Sell Areas - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Long term hold vs stop loss in NLS Pharmaceutics AG Equity WarrantLong-Term Growth Trend Summary With Confidence - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Analyzing NLS Pharmaceutics AG with multi timeframe chartsFree Early Entry Tips With Low Risk Zone - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Can momentum traders help lift NLS Pharmaceutics AG Equity WarrantLow Risk Stock Trade Opportunity Analysis - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Why NLS Pharmaceutics AG stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

How NLS Pharmaceutics AG stock performs during market volatilityFree High Yield Stock Screening Results - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Analysts Apply Wyckoff Model to NLS Pharmaceutics AG StockWatchlist for Low Risk High Return Stocks Updated - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

When is NLS Pharmaceutics AG stock expected to show significant growthFree Stock Selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is NLS Pharmaceutics AG a good long term investmentMaximize gains with timely market signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does NLS Pharmaceutics AG Equity Warrant generate profit in a changing economyBuild wealth with reliable stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell NLS Pharmaceutics AG stock in 2025Achieve breakthrough financial results today - Jammu Links News

Aug 03, 2025

Finanzdaten der Nls Pharmaceutics Ag-Aktie (NLSPW)

Es liegen keine Finanzdaten für Nls Pharmaceutics Ag (NLSPW) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
Kapitalisierung:     |  Volumen (24h):